Kedokteran & Kesehatan editorial
Open AccessOA2025
Osteoarthritis Year in Review 2025: Epidemiology and Therapy
This narrative review synthesizes 41 key studies on osteoarthritis epidemiology and therapy from 2024โ2025, highlighting the rising global burden, the role of body composition and comorbidities, and the limited efficacy of current interventions, while pointing to obesity-targeted therapies like semaglutide as promising avenues for disease modification.
A. Dell'isola; Filippo Recenti; B. Giardulli; B. Lawford; A. Kiadaliriยท Osteoarthritis and Cartilageยท 2025ยท DOI 10.1016/j.joca.2025.08.015
The core problem
Osteoarthritis (OA) is a leading cause of disability worldwide, and its burden continues to grow. The aim of this review was to summarise key epidemiological and therapeutic research on OA published between April 2024 and March 2025, providing a snapshot of recent advances and persistent challenges. The authors focused on studies that identify risk factors or advance treatment strategies, reflecting the complexity of OA as a whole-joint disease influenced by metabolic, biomechanical, and psychosocial factors.
Innovation
A narrative review was conducted using the MEDLINE database, targeting English-language studies involving human participants published between April 1, 2024, and March 31, 2025. Eligible designs included observational longitudinal studies, systematic reviews, meta-analyses, and phase IIโIV randomised controlled trials (RCTs) examining OA treatment and epidemiology. Three authors screened a total of 1,920 studies, of which 133 were considered for potential inclusion. Ultimately, 41 studies were selected based on their perceived importance and relevance to identifying risk factors or advancing OA treatment.
Introduction
Osteoarthritis (OA) is a leading cause of disability worldwide, and its burden continues to grow. The aim of this review was to summarise key epidemiological and therapeutic research on OA published between April 2024 and March 2025, providing a snapshot of recent advances and persistent challenges. The authors focused on studies that identify risk factors or advance treatment strategies, reflecting the complexity of OA as a whole-joint disease influenced by metabolic, biomechanical, and psychosocial factors.
Why it matters
The past year's research highlights the complexity of OA and the limited effectiveness of current interventions. While therapies targeting obesity hold promise, further research is needed to confirm their role in disease modification. Personalised treatment approaches that integrate metabolic, biomechanical, and psychosocial factors may be crucial for advancing OA care management. The findings underscore the need for a shift away from one-size-fits-all treatments toward tailored strategies that address the heterogeneous nature of OA.
Who should read this
Pembaca Research Digest dan praktisi rumpun ini.
Opening member contentโฆ